世界の神経芽腫治療薬市場は2023年に約7億4,000万米ドルと評価され、2024年から2032年の予測期間にわたって6.2%を超える健全な成長率で成長すると予想されています。
神経芽腫は主に5歳未満の幼児に発生するがんで、腎臓の上にある副腎の神経組織に由来します。神経芽細胞と呼ばれる未熟な神経細胞から発生し、多様な症状と結果で知られています。腹部のしこり、排便パターンの変化、骨の不快感、疲労、皮膚の変化など、その症状は多岐にわたります。神経芽腫治療薬は神経芽腫と闘うために調整された薬です。これにはシスプラチンやエトポシドなどの化学療法薬、ALK遺伝子を標的とするクリゾチニブなどの標的療法、ジヌツキシマブなどの免疫療法、レチノイン酸などの分化誘導剤、I-131 MIBGなどの放射性医薬品が含まれます。治療計画はがんのステージや患者の健康などの要因に基づいて個別に行われ、専門家チームが効果を最適化するために設計した治療法の組み合わせが含まれます。個別化医療と標的療法への移行の高まりは、世界の神経芽腫治療薬市場にとって重要なトレンドです。医薬品開発者は、神経芽腫に関連する遺伝子異常や生物学的プロセスを特に標的とする医薬品の開発に注力しています。この方法は、より集中的で効率的な治療を可能にすることで副作用を軽減し、患者の転帰を改善します。
さらに、神経芽腫治療薬市場に影響を与える主な推進要因には、医療技術の進歩が含まれ、神経芽腫患者の診断と治療の選択肢が向上しています。また、神経芽腫に関する意識の高まりと早期発見の取り組みは、神経芽腫治療薬の需要に貢献しています。さらに、標的療法と免疫療法の開発に焦点を当てた継続的な研究開発の取り組みは、市場の成長をさらに推進しています。製薬会社は、この病気のより効果的な治療法に対するアンメットニーズに対応するために、新しい神経芽腫治療薬の研究開発（R＆D）に多額の投資を行っています。このR＆D活動の増加の結果、患者の転帰を改善する可能性のあるいくつかの新しい神経芽腫治療薬がパイプラインにあります。さらに、製薬会社、学術機関、およびヘルスケア組織間のコラボレーションにより、革新と新しい神経芽腫治療薬の市場への導入が促進され、推定期間中に世界の神経芽腫治療薬市場にさまざまな成長の見通しがさらに提示されています。しかし、神経芽腫治療薬に伴う有害な副作用と、薬剤承認に関する厳格な規制要件により、2022年から2032年の間に世界の神経芽腫治療薬市場の成長が抑制されると予想されます。
世界の神経芽腫治療薬市場調査で検討されている主要な地域には、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域が含まれます。2023年には、神経芽腫治療薬の入手可能性の向上、政府の支援的な取り組み、強力な規制の支援、確立された医療制度など、いくつかの要因により、北アメリカが神経芽腫治療薬市場で支配的な地位を占めました。さらに、この地域は、製品の承認やパートナーシップなどの戦略的取り組みに積極的に取り組んでいる主要な業界プレーヤーの存在から恩恵を受けており、北アメリカの市場拡大に大きく貢献しています。一方、アジア太平洋地域は、予測期間中に急速な成長が見込まれています。
目次
Table of Contents
Chapter 1. Global Neuroblastoma Drugs Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
Chapter 2. Executive Summary
2.1. Global Neuroblastoma Drugs Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Type
2.3.2. By Route of Administration
2.3.3. By Distribution Channel
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Global Neuroblastoma Drugs Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Global Neuroblastoma Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Neuroblastoma Drugs Market Size & Forecasts by Type 2022-2032
5.1. Chemotherapy
5.2. Immunotherapy
5.3. Others
Chapter 6. Global Neuroblastoma Drugs Market Size & Forecasts by Route of Administration 2022-2032
6.1. Oral
6.2. Injectable
Chapter 7. Global Neuroblastoma Drugs Market Size & Forecasts by Distribution Channel 2022-2032
7.1. Online
7.2. Offline
Chapter 8. Global Neuroblastoma Drugs Market Size & Forecasts by Region 2022-2032
8.1. North America Neuroblastoma Drugs Market
8.1.1. U.S. Neuroblastoma Drugs Market
8.1.1.1. Type breakdown size & forecasts, 2022-2032
8.1.1.2. Route of Administration breakdown size & forecasts, 2022-2032
8.1.1.3. Distribution Channel breakdown size & forecasts, 2022-2032
8.1.2. Canada Neuroblastoma Drugs Market
8.2. Europe Neuroblastoma Drugs Market
8.2.1. U.K. Neuroblastoma Drugs Market
8.2.2. Germany Neuroblastoma Drugs Market
8.2.3. France Neuroblastoma Drugs Market
8.2.4. Spain Neuroblastoma Drugs Market
8.2.5. Italy Neuroblastoma Drugs Market
8.2.6. Rest of Europe Neuroblastoma Drugs Market
8.3. Asia-Pacific Neuroblastoma Drugs Market
8.3.1. China Neuroblastoma Drugs Market
8.3.2. India Neuroblastoma Drugs Market
8.3.3. Japan Neuroblastoma Drugs Market
8.3.4. Australia Neuroblastoma Drugs Market
8.3.5. South Korea Neuroblastoma Drugs Market
8.3.6. Rest of Asia Pacific Neuroblastoma Drugs Market
8.4. Latin America Neuroblastoma Drugs Market
8.4.1. Brazil Neuroblastoma Drugs Market
8.4.2. Mexico Neuroblastoma Drugs Market
8.4.3. Rest of Latin America Neuroblastoma Drugs Market
8.5. Middle East & Africa Neuroblastoma Drugs Market
8.5.1. Saudi Arabia Neuroblastoma Drugs Market
8.5.2. South Africa Neuroblastoma Drugs Market
8.5.3. Rest of Middle East & Africa Neuroblastoma Drugs Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Recordati Group
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Eli Lilly and Company
9.3.3. Bristol-Myers Squibb Company
9.3.4. Y-mabs Therapeutics, Inc.
9.3.5. MacroGenics Inc.
9.3.6. AstraZeneca plc
9.3.7. United Therapeutics Corporation
9.3.8. Pfizer Inc.
9.3.9. Teva Pharmaceutical Industries Ltd.
9.3.10. Cellectar Biosciences, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
List of Tables
TABLE 1. Global Neuroblastoma Drugs Market, report scope
TABLE 2. Global Neuroblastoma Drugs Market estimates & forecasts by Region 2022-2032 (USD Million)
TABLE 3. Global Neuroblastoma Drugs Market estimates & forecasts by Type 2022-2032 (USD Million)
TABLE 4. Global Neuroblastoma Drugs Market estimates & forecasts by Route of Administration 2022-2032 (USD Million)
TABLE 5. Global Neuroblastoma Drugs Market estimates & forecasts by Distribution Channel 2022-2032 (USD Million)
TABLE 6. Global Neuroblastoma Drugs Market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. Global Neuroblastoma Drugs Market by region, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. Global Neuroblastoma Drugs Market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. Global Neuroblastoma Drugs Market by region, estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. Global Neuroblastoma Drugs Market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 11. Global Neuroblastoma Drugs Market by region, estimates & forecasts, 2022-2032 (USD Million)
TABLE 12. Global Neuroblastoma Drugs Market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 13. Global Neuroblastoma Drugs Market by region, estimates & forecasts, 2022-2032 (USD Million)
TABLE 14. Global Neuroblastoma Drugs Market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 15. Global Neuroblastoma Drugs Market by region, estimates & forecasts, 2022-2032 (USD Million)
TABLE 16. U.S. Neuroblastoma Drugs Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 17. U.S. Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 18. U.S. Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 19. Canada Neuroblastoma Drugs Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 20. Canada Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 21. Canada Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 22. UK Neuroblastoma Drugs Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 23. UK Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 24. UK Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 25. Germany Neuroblastoma Drugs Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 26. Germany Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 27. Germany Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 28. France Neuroblastoma Drugs Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 29. France Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 30. France Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 31. Italy Neuroblastoma Drugs Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 32. Italy Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 33. Italy Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 34. Spain Neuroblastoma Drugs Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 35. Spain Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 36. Spain Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 37. RoE Neuroblastoma Drugs Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 38. RoE Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 39. RoE Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 40. China Neuroblastoma Drugs Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 41. China Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 42. China Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 43. India Neuroblastoma Drugs Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 44. India Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 45. India Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 46. Japan Neuroblastoma Drugs Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 47. Japan Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 48. Japan Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 49. Australia Neuroblastoma Drugs Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 50. Australia Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 51. Australia Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 52. South Korea Neuroblastoma Drugs Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 53. South Korea Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 54. South Korea Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 55.
TABLE 56. RoAPAC Neuroblastoma Drugs Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 57. RoAPAC Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 58. RoAPAC Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 59. Brazil Neuroblastoma Drugs Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 60. Brazil Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 61. Brazil Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 62. Mexico Neuroblastoma Drugs Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 63. Mexico Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 64. Mexico Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 65. RoLA Neuroblastoma Drugs Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 66. RoLA Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 67. RoLA Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 68. Saudi Arabia Neuroblastoma Drugs Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 69. Saudi Arabia Neuroblastoma Drugs Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 70. Saudi Arabia Neuroblastoma Drugs Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 71. South Africa Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 72.
TABLE 73. South Africa Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 74. South Africa Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 75. RoMEA Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 76. RoMEA Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 77. RoMEA Neuroblastoma Drugs Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 78. List of secondary sources, used in the study of Global Neuroblastoma Drugs Market.
TABLE 79. List of primary sources, used in the study of Global Neuroblastoma Drugs Market.
TABLE 80. Years considered for the study.
TABLE 81. Exchange rates considered.
List of figures
FIG 1. Global Neuroblastoma Drugs Market, research methodology
FIG 2. Global Neuroblastoma Drugs Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods.
FIG 4. Global Neuroblastoma Drugs Market, key trends 2023
FIG 5. Global Neuroblastoma Drugs Market, growth prospects 2022-2032
FIG 6. Global Neuroblastoma Drugs Market, porters 5 force model
FIG 7. Global Neuroblastoma Drugs Market, pestel analysis
FIG 8. Global Neuroblastoma Drugs Market, value chain analysis
FIG 9. Global Neuroblastoma Drugs Market by segment, 2022 & 2032 (USD Million)
FIG 10. Global Neuroblastoma Drugs Market by segment, 2022 & 2032 (USD Million)
FIG 11. Global Neuroblastoma Drugs Market by segment, 2022 & 2032 (USD Million)
FIG 12. Global Neuroblastoma Drugs Market by segment, 2022 & 2032 (USD Million)
FIG 13. Global Neuroblastoma Drugs Market by segment, 2022 & 2032 (USD Million)
FIG 14. Global Neuroblastoma Drugs Market, regional snapshot 2022 & 2032
FIG 15. North America Neuroblastoma Drugs Market 2022 & 2032 (USD Million)
FIG 16. Europe Neuroblastoma Drugs Market 2022 & 2032 (USD Million)
FIG 17. Asia pacific Neuroblastoma Drugs Market 2022 & 2032 (USD Million)
FIG 18. Latin America Neuroblastoma Drugs Market 2022 & 2032 (USD Million)
FIG 19. Middle East & Africa Neuroblastoma Drugs Market 2022 & 2032 (USD Million)
FIG 20. Global Neuroblastoma Drugs Market, company market share analysis (2023)
